Bio-Rad Laboratories (BIO) Capital Expenditures (2009 - 2026)

Bio-Rad Laboratories (BIO) has 18 years of Capital Expenditures data on file, last reported at $30.0 million in Q1 2026.

• On a quarterly basis, Capital Expenditures fell 12.79% year-over-year to $30.0 million in Q1 2026; TTM through Mar 2026 was $153.2 million, a 4.13% decrease from a year earlier, with the FY2025 full-year figure at $157.6 million, down 4.83% from the prior year.
• Capital Expenditures for Q1 2026 stood at $30.0 million, down from $45.8 million in the prior quarter.
• Over the last five years, Capital Expenditures for BIO reached as high as $45.8 million in Q4 2025 and fell as low as $17.3 million in Q2 2022.
• Historically, Capital Expenditures has averaged $36.6 million across 5 years, with a median of $35.7 million in 2023.
• Across the five-year window, Capital Expenditures slumped 38.04% in 2022 and surged 99.83% in 2023, its largest moves.
• Year by year, Capital Expenditures stood at $34.8 million in 2022, then increased by 21.41% to $42.3 million in 2023, then gained by 1.5% to $42.9 million in 2024, then grew by 6.76% to $45.8 million in 2025, then slumped by 34.5% to $30.0 million in 2026.
• Per Business Quant data, the three most recent Capital Expenditures figures were $30.0 million in Q1 2026, $45.8 million in Q4 2025, and $31.7 million in Q3 2025.